Advertisement

Rivoceranib

Reversible posterior leukoencephalopathy syndrome: case report

    • 21 Accesses

    This is a preview of subscription content, log in to check access.

    Access options

    Buy single article

    Instant unlimited access to the full article PDF.

    US$ 49.95

    Price includes VAT for USA

    Reference

    1. Lv Y, et al. Reversible posterior leukoencephalopathy syndrome following apatinib for gastric cancer in an adult: A case report and a review of the literature. Medicine 98: No. 46, Nov 2019. Available from: URL: http://doi.org/10.1097/MD.0000000000017787

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Rivoceranib. Reactions Weekly 1786, 148 (2020). https://doi.org/10.1007/s40278-020-73622-2

    Download citation